Plus Therapeutics (PSTV) Misses Q3 EPS by 37c

Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.37). Revenue for the quarter came in at $1.45 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• FDA approves Tylenol with Naproxen as first OTC combo pain reliever
• Pakistan, Iran Explore Path Towards New Talks With US In A China-initiated Push, Sources Say - Reuters